Clinical Study
Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease
Table 2
Comparison of serum biochemistries in the study and control groups.
| | | Basal | Final | P value |
| | Study group () | | | | | hs-CRP (mg/L) | 4.9 (3.3–7.7) | 4.5 (2.8–6.3) | <0.01 | | TNF- (pg/mL) | 7.8 (5.1–9.0) | 6.3 (4.9–8.2) |
0.01 | | Interleukin-6 (pg/mL) | 6.5 (2–12) | 5.9 (1.8–11.6) | <0.05 | | Interleukin-10 (pg/mL) | 67 (41–125) | 74 (52–119) | NS | | Control group () | | | | | hs-CRP (mg/L) | 4.9 (3.9–8.0) | 4.9 (4.2–7.7) | NS | | TNF- (pg/mL) | 7.6 (5.5–9.2) | 7.4 (5.2–9.1) | NS | | Interleukin-6 (pg/mL) | 6.8 (2.8–11.2) | 7.0 (2.4–11) | NS | | Interleukin-10 (pg/mL) | 72 (32–101) | 66 (35–99) | NS |
|
|
Ca × P: calcium-phosphate product; PTH: parathyroid hormone; hs-CRP: high-sensitive C-reactive protein; TNF-: tumor necrosis factor-; NS: not significant.
|
